Ultrasound technologist working in Alberta speaks out about her experience with vaccine side effects
An ultrasound technologist working in Alberta and who specialized in musculoskeletal ultrasound imaging with 26 years of experience has decided to speak out about COVID-19 vaccine side effects to Lakeland Connect.
Her name is being withheld for personal protection as she fears she will receive backlash from the Alberta Government for speaking out and for breaking patient confidentiality.
She was laid off by the Alberta Government when she refused to take the COVID-19 vaccine.
“In the three to four weeks proceeding my first layoff, I saw at least four strange neurological reactions that I believe are from the vaccine,” she said.
“This was just in my one ultrasound room out of 18 rooms in my clinic,” the ultrasound technologist told Lakeland Connect. “I have no idea how many injured persons went through my colleague’s rooms without being noticed.”
She says she had two people present with severe pain in their fingers running up their arm, numbness in their hand and arm, and muscle spasms in their arm which presented within a couple of days to a couple of weeks after their vaccinations.
“I had one older lady, perhaps 65, who had developed loss of balance since her first vaccine,” she said. “She could barely walk down the hallway without my assistance. She had to hold the railing because she kept falling towards the left side.”
The ultrasound technologist also had another older fellow who presented massive bruising down his arm after being vaccinated.
“His doctor suspected he had torn his long head of the biceps tendon, which would have been a common occurrence in an older man,” she said. “However, when I did his ultrasound, I found that his bicep tendon was healthy. The massive bleeding was actually from a hole/tear that had formed in his deltoid muscle ( the one most commonly used to inject vaccines into – although I cannot confirm if this was where he got his injection). In my entire 26 years of ultrasound, I have never seen such a thing, especially without any type of trauma to cause it.”
She also told Lakeland Connect about her girlfriend, 41, who had a stroke six weeks after her second dose, and while doctors were investigating that they also discovered MS.
“She is way too old to be first presenting with symptoms of MS,” she said. “That disease tends to manifest itself in the late teens and early 20s.”
She believes the diagnosis could have been wrong, not that the vaccine causes MS.
*According to the Multiple Sclerosis (MS) Society of Canada the majority of people diagnosed with MS are between the ages of 20 and 49 years old.
A relative of hers also had her new double vaccinated Father in law get diagnosed with stage four lung cancer, but he was given 8-10 months, but subsequently passed in only six weeks after vaccination.
According to Health Canada, a total of 68,229,041 vaccine doses have been administered in Canada as of December 31, 2021. Adverse side effects have been reported by 32,514 people. That’s about 5 people out of every 10,000 people vaccinated who have reported one or more adverse events.
Of the 32,514 individual reports, 25,388 were considered non-serious (0.037% of all doses administered) and 7,126 were considered serious (0.010% of all doses administered), Health Canada stated.
“Most adverse events are mild and include soreness at the site of injection or a slight fever,” Health Canada said. “Serious adverse events are rare, but do occur. They include anaphylaxis (a severe allergic reaction), which has been reported 729 times for all COVID-19 vaccines across Canada. That’s why you need to wait for a period of time after you receive a vaccination so that you can receive treatment in case of an allergic reaction.”
Health Canada says, “All serious events undergo medical review to see if there are any safety issues needing further action. These processes include meeting regularly to review the data with provincial and territorial partners, the regulator, research networks and medical advisors. Any unexpected safety concerns are detected quickly and acted upon immediately.”
Rare reactions that have been reported
As with all vaccines, there’s a very small chance that there will be a serious side effect, Health Canada says.
Most side effects (95 per cent) are reported within the first 42 days following immunization.
- The Public Health Agency of Canada (PHAC) and Health Canada continue to closely monitor Canadian and international reports of:
- Thrombosis with thrombocytopenia syndrome following vaccination with AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine. Health Canada has updated the AstraZeneca Vaxzevria COVID-19 vaccine product monograph (PDF) and the COVISHIELD COVID-19 vaccine product monograph (PDF) to include information about these very rare events of blood clots associated with low levels of platelets following immunization. For more information, please refer to the AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine public advisory.
- Guillain-Barré Syndrome (GBS) in Canada following AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination. Data in Canada indicate a higher number of reports than would normally be expected in the general population. Health Canada has updated the AstraZeneca Vaxzevria COVID-19 vaccine product monograph (PDF) and the COVISHIELD COVID-19 vaccine product monograph (PDF) to include information on GBS. For more information, please refer to the AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination product description.
- Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines. Data in Canada indicate a higher number of reports in younger people (i.e. less than 40 years of age) than would normally be expected in this age group in the general population. Health Canada updated the Moderna Spikevax COVID-19 vaccine product monograph (PDF) and the Pfizer-BioTech Comirnaty COVID-19 vaccines product monograph (PDF) to include information around these risks. For more information, please refer to the Moderna Spikevax and Pfizer-BioNTech Comirnaty COVID-19 vaccines public advisory.
- Capillary leak syndrome following vaccination with the AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine. Health Canada has updated the AstraZeneca Vaxzevria COVID-19 vaccine product monograph (PDF) and the COVISHIELD COVID-19 vaccine product monograph (PDF) to include information on capillary leak syndrome, including a contraindication for patients who have previously experienced this syndrome. For more information, please refer to the AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine public advisory.
- Facial paralysis/Bell’s Palsy following COVID-19 vaccination. Health Canada has updated Moderna Spikevax COVID-19 vaccine product monograph (PDF) and the Pfizer-BioNTech Comirnaty COVID-19 vaccine product monograph (PDF) to include information on facial paralysis/Bell’s Palsy.
- Immune thrombocytopenia (ITP) and venous thromboembolism (VTE) following vaccination with the Janssen COVID-19 vaccine. Health Canada has updated the Janssen COVID-19 vaccine product monograph (PDF) to include information on ITP and VTE. For more information, please refer to the Janssen and AstraZeneca Vaxzevria COVID-19 vaccines public advisory.
- Thrombocytopenia including ITP following vaccination with AstraZeneca Vaxzevria COVID-19 vaccine. Health Canada has updated the AstraZeneca Vaxzevria COVID-19 vaccine product monograph (PDF) to include information on thrombocytopenia including ITP. For more information, please refer to the AstraZeneca Vaxzevria COVID-19 vaccine public advisory.
However, Health Canada says, the benefits of vaccines authorized in Canada continue to outweigh the risks.
Have you experienced any adverse side effects from the vaccination? If so please email your experience to Arthur@lakelandconnect.thedev.ca
news via inbox
Get Connected! Sign up for daily news updates.